Quanterix Launches Multiplexed Single Molecule Immunoassay Technology to Improve Diagnosis and Potential Treatment of Complex Diseases
Published: Sep 17, 2013
LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation, delivering the world’s most sensitive single molecule immunoassay measurement for the benefit of human health, today announced its recently published Multiplexed Single Molecule Immunoassays study that successfully demonstrated the ability to measure multiple proteins simultaneously at the single molecule level using its Simoa technology. The study, published in May by the Royal Society of Chemistry, was funded in part by a grant from the National Cancer Institute.
Help employers find you! Check out all the jobs and post your resume.